---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-231310"
form_type: "8-K"
ticker: "ENTA"
cik: "0001177648"
company_name: "ENANTA PHARMACEUTICALS INC"
filed_at: "2022-08-26T23:59:59+00:00"
generated_at: "2026-06-23T20:50:00.579436+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Enanta Pharmaceuticals enters ATM agreement with Jefferies for up to $100M common stock offering

## Summary
- Open Market Sale Agreement with Jefferies LLC allows at-the-market sales of up to $100M in common stock.
- Jefferies will receive a 3.0% commission on gross sales price per share sold under the agreement.
- Shares sold on Nasdaq Global Select Market or other trading venues; company has no obligation to sell.
- Offering terminates upon sale of all shares or termination of the agreement per its terms.

## SEC filing metadata
- accession: 0001193125-22-231310
- form_type: 8-K
- ticker: ENTA
- cik: 0001177648
- company_name: ENANTA PHARMACEUTICALS INC
- filed_at: 2022-08-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1177648/000119312522231310/0001193125-22-231310-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1177648/000119312522231310/d376393d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-231310
- JSON: https://secwatch.observer/filing/0001193125-22-231310.json
- Plain text: https://secwatch.observer/filing/0001193125-22-231310.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.